Electroconvulsive Therapy Augmentation in Clozapine-resistant Schizophrenia: a Prospective, Randomized Study

Electroconvulsive Therapy Augmentation in Clozapine-resistant Schizophrenia: a Prospective, Randomized Study is organized by University of Cincinnati Continuing Medical Education (UC-CME).

Release: April 21, 2022
Expires: April 21, 2024

Overview:
Department Psychiatry and Behavioral Neuroscience Endured Journal Club

Objectives:
As a result of participating in this activity, participants should be able to:
• Recognize the effectiveness of ECT augmentation in clozapine-resistant schizophrenia;
• Identify patient population in which ECT augmentation for symptoms of schizophrenia may be effective;
• Examine the limitations of study data and the need for further research.

Additional Details Will Be Posted as Soon as Information is Available.

1.0 AMA PRA Category 1 Credit™ | 1.0 Hours